All patients underwent TPL and FJT for biopsy-proven squamous cell carcinoma (SCC) at our institution from April 2010 to April 2023 were included. Exclusion criteria were: (1) patients underwent TPL and FJT for non-SCC, (2) patients underwent TPL and FJT in conjunction with total esophagectomy and (3) patients with prior history of total esophagectomy.
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients underwent TPL and FJT for biopsy-proven squamous cell carcinoma (SCC) at our institution from April 2010 to April 2023 were included.
Exclusion criteria
Exclusion criteria: Exclusion criteria were: (1) patients underwent TPL and FJT for non-SCC, (2) patients underwent TPL and FJT in conjunction with total esophagectomy and (3) patients with prior history of total esophagectomy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint was the incidence of tracheal necrosis. | — |
Countries
Japan
Contacts
National Cancer Center Hospital East, Kashiwa, Japan Department of Plastic and Reconstructive Surgery